Canaccord Lowers Price Target for Smith & Nephew Ahead of Q1 Results
Canaccord cut its price target on Smith & Nephew (SNN) to $32 from $35 ahead of the company's fiscal first-quarter results, maintaining a Hold rating. Meanwhile, RBC Capital raised SNN’s price target in anticipation of an upcoming capital markets day.
Tickers: $SNN
Topics: Analyst Rating Clinical Trial Results Earnings Outlook Medical Devices